Source link : https://www.newshealth.biz/health-news/fda-revokes-euas-of-four-covid-19-monoclonal-antibodies/
The FDA on Friday revoked the emergency use authorizations (EUAs) of four monoclonal antibodies for COVID-19. The four drugs — bebtelovimab, sotrovimab, casirivimab/imdevimab (REGN-COV2), and tixagevimab/cilgavimab (Evusheld) — had been authorized for COVID-19 as treatments or as pre- or post-exposure prophylaxis for individuals at high risk of severe outcomes. Casirivimab/imdevimab had famously been used in […]
Author : News Health
Publish date : 2024-12-13 22:02:43
Copyright for syndicated content belongs to the linked Source.